Mariner, LLC Agenus Inc Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $385 - $676	727 Added 1.84%	40,328 $23,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $24,948 - $45,145	39,601 New	39,601 $32,000
Q1 2023 May 12, 2023	SELL	$1.45 - $2.95 $5,346 - $10,876	-3,687 Reduced 23.99%	11,684 $18,000
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $997 - $1,605	-494 Reduced 3.11%	15,371 $37,000
Q3 2022 Nov 10, 2022	BUY	$1.96 - $3.14 $31,095 - $49,816	15,865 New	15,865 $33,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.